Reminder!
The tier level is assigned to the guideline, NOT to the specific search terms. For example, a Tier 1 guideline has at least one recommendation that meets criteria for Tier 1, but also could include tier 2 or 3 recommendations.
DO read the guidelines to find out about specific search terms.
DON’T rely on the overall tier classification of the guideline for the specified search terms.
See More FAQ
Publication | Tier |
---|---|
Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes.
Frebourg Thierry et al. European journal of human genetics : EJHG 2020 May |
|
An evidence-based guideline on the application of molecular testing in the diagnosis, prediction of prognosis, and selection of therapy in non-GIST soft tissue sarcomas.
Yao Xiaomei et al. Cancer treatment reviews 2020 Feb 85101987 |
|
Clinical worthlessness of genetic prediction of common forms of diabetes mellitus and related chronic complications.: A position statement of the Italian Society of Diabetology.
Buzzetti R et al. Nutrition, metabolism, and cardiovascular diseases : NMCD 2016 Aug |
|
Guidelines for Genomic Array Analysis in Acquired Haematological Neoplastic Disorders.
Schoumans Jacqueline et al. Genes, chromosomes & cancer 2016 Jan |
|
Local Coverage Determination (LCD) for Breast Cancer Assay
The Centers for Medicare & Medicaid Services (CMS) |